These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34446373)

  • 1. Differential Impact of Type 1 and Type 2 Diabetes Mellitus on Outcomes Among 1.4 Million US Patients Undergoing Percutaneous Coronary Intervention.
    Matetic A; Doolub G; Bharadwaj A; Osman M; Biondi-Zoccai G; Ullah W; Bagur R; Velagapudi P; Alraies MC; Mohamed MO; Mamas MA
    Cardiovasc Revasc Med; 2022 May; 38():83-88. PubMed ID: 34446373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Diabetes Mellitus and Its Types with In-Hospital Management and Outcomes of Patients with Acute Myocardial Infarction.
    Sethupathi P; Matetić A; Bang V; Myint PK; Rendon I; Bagur R; Diaz-Arocutipa C; Ricalde A; Bharadwaj A; Mamas MA
    Cardiovasc Revasc Med; 2023 Jul; 52():16-22. PubMed ID: 36854639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort.
    Wang P; Yuan D; Zhang C; Zhu P; Jia S; Song Y; Tang X; Xu J; Li T; Zeng G; Zhao X; Yang Y; Xu B; Gao R; Yuan J
    Cardiovasc Diabetol; 2022 Mar; 21(1):46. PubMed ID: 35313877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of body mass index on long-term outcomes in patients undergoing percutaneous coronary intervention stratified by diabetes mellitus: a retrospective cohort study.
    Rao C; Zhong Q; Wu R; Li Z; Duan Y; Zhou Y; Wang C; Chen X; Wang R; He K
    BMC Cardiovasc Disord; 2024 Feb; 24(1):113. PubMed ID: 38365597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of Extracardiac Vascular Disease and Outcomes in Patients With Diabetes (1.1 Million) Hospitalized for Acute Myocardial Infarction.
    Istanbuly S; Matetic A; Roberts DJ; Myint PK; Alraies MC; Van Spall HG; Mohamed MO; Bharadwaj A; Mamas MA
    Am J Cardiol; 2022 Jul; 175():8-18. PubMed ID: 35550818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention.
    Bashar H; Matetić A; Curzen N; Mamas MA
    Catheter Cardiovasc Interv; 2022 Nov; 100(5):737-746. PubMed ID: 36129816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-hospital, short-term and long-term adverse clinical outcomes observed in patients with type 2 diabetes mellitus vs non-diabetes mellitus following percutaneous coronary intervention: A meta-analysis including 139,774 patients.
    Zhuo X; Zhang C; Feng J; Ouyang S; Niu P; Dai Z
    Medicine (Baltimore); 2019 Feb; 98(8):e14669. PubMed ID: 30813214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High neutrophil to lymphocyte ratio with type 2 diabetes mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study.
    He J; Bian X; Song C; Zhang R; Yuan S; Yin D; Dou K
    Cardiovasc Diabetol; 2022 Aug; 21(1):156. PubMed ID: 35964050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.
    Baber U; Stefanini GG; Giustino G; Stone GW; Leon MB; Sartori S; Aquino M; Steg PG; Windecker S; Wijns W; Serruys PW; Valgimigli M; Morice MC; Camenzind E; Weisz G; Smits PC; Kandzari DE; von Birgelen C; Dangas GD; Galatius S; Jeger RV; Kimura T; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Kastrati A; Chieffo A; Mehran R
    Circ Cardiovasc Interv; 2019 Jul; 12(7):e007734. PubMed ID: 31288561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Noman A; Balasubramaniam K; Alhous MHA; Lee K; Jesudason P; Rashid M; Mamas MA; Zaman AG
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1195-1204. PubMed ID: 28029209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus.
    Grodzinsky A; Kosiborod M; Tang F; Jones PG; McGuire DK; Spertus JA; Beltrame JF; Jang JS; Goyal A; Butala NM; Yeh RW; Arnold SV
    Circ Cardiovasc Qual Outcomes; 2017 Sep; 10(9):. PubMed ID: 28904076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Outcomes of Patients With Versus Without Chronic Liver Disease Undergoing Percutaneous Coronary Intervention.
    Istanbuly S; Matetic A; Mohamed MO; Panaich S; Velagapudi P; Elgendy IY; Paul TK; Alkhouli M; Mamas MA
    Am J Cardiol; 2021 Oct; 156():32-38. PubMed ID: 34348842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of diabetes mellitus on all and successful percutaneous coronary intervention outcomes for chronic total occlusions: A systematic review and meta-analysis.
    Guan J; Li X; Gong S; Li L
    Heart Lung; 2022; 55():108-116. PubMed ID: 35533491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of diabetes on the prognostic value of left ventricular function following percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society.
    Jackson M; Austin D; Kwok CS; Rashid M; Kontopantelis E; Ludman P; de Belder M; Mamas MA; Zaman A
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):E393-E402. PubMed ID: 29726633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality.
    Bawamia BR; Egred M; Jackson M; Purcell I; Austin D; Zaman AG
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):E416-E422. PubMed ID: 32134178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China.
    Qin Z; Zhou K; Li Y; Cheng W; Wang Z; Wang J; Gao F; Yang L; Xu Y; Wu Y; He H; Zhou Y
    Cardiovasc Diabetol; 2020 Feb; 19(1):23. PubMed ID: 32085772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes Mellitus and Long-Term Risk for Heart Failure After Coronary Revascularization.
    Takeji Y; Shiomi H; Morimoto T; Furukawa Y; Ehara N; Nakagawa Y; Kato T; Tazaki J; Kato ET; Yaku H; Yoshikawa Y; Tada T; Hanyu M; Kadota K; Komiya T; Ando K; Kimura T;
    Circ J; 2020 Feb; 84(3):471-478. PubMed ID: 31996490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
    Park KW; Lee JM; Kang SH; Ahn HS; Kang HJ; Koo BK; Rhew JY; Hwang SH; Lee SY; Kang TS; Kwak CH; Hong BK; Yu CW; Seong IW; Ahn T; Lee HC; Lim SW; Kim HS
    JACC Cardiovasc Interv; 2014 May; 7(5):471-81. PubMed ID: 24852802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year Outcomes After Drug-Eluting Stents or Bypass Surgery for Left Main Coronary Disease in Patients With and Without Diabetes Mellitus: The PRECOMBAT Extended Follow-Up Study.
    Jeong YJ; Ahn JM; Hyun J; Lee J; Kim JH; Yang Y; Choe K; Park H; Kang DY; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park SJ; Park DW
    J Am Heart Assoc; 2021 Jul; 10(14):e019834. PubMed ID: 34238026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery bypass surgery compared with percutaneous coronary interventions in patients with insulin-treated type 2 diabetes mellitus: a systematic review and meta-analysis of 6 randomized controlled trials.
    Bundhun PK; Wu ZJ; Chen MH
    Cardiovasc Diabetol; 2016 Jan; 15():2. PubMed ID: 26739589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.